0.02
+0(+0.00%)
Currency In USD
Address
3 More London Riverside
London, SE1 2AQ
United Kingdom of Great Britain and Northern Ireland
Phone
44 11 7284 2535
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1210
First IPO Date
March 19, 2021
| Name | Title | Pay | Year Born |
| Ms. Veronique Ameye Esq., M.B.A. | Deputy Chief Executive Officer & General Counsel | 0 | 1977 |
| Ms. Veronique Ameye M.B.A. | Deputy Chief Executive Officer & Gen. Counsel | 0 | 1977 |
| Ms. Veronique Ameye EMBA, Esq., M.B.A. | Chief Executive Officer & General Counsel | 0 | 1977 |
| Mr. Ron Zwanziger | Co-Founder, Chairman & Chief Executive Officer | 0 | 1954 |
| Dr. Nigel Lindner | Chief Innovation Officer | 0 | 1957 |
| Ms. Veronique Ameye | Executive Vice President & Gen. Counsel | 0 | 1977 |
| Giffin Daughtridge | President of North America Commercial Operations & Global Molecular Solutions | 0 | N/A |
| Mr. Peter Scheu | Pres of North American Commercial Operations | 0 | 1965 |
| Melissa Garcia | Vice President & Corporate Counsel | 0 | N/A |
| Dr. David Scott Ph.D. | Co-Founder, Chief Technology Officer & Director | 0 | 1957 |
| Dr. Jerome F. McAleer Ph.D. | Co-Founder, Chief Scientist & Director | 0 | 1956 |
| Mr. Dorian LeBlanc CPA | Chief Financial Officer & Vice President of Global Operations | 0 | 1975 |
| Ms. Colleen McMillen | Vice President of Communications | 0 | N/A |
| Andy Ward | National Sales Director - UK | 0 | N/A |
| Mr. David Walton DMS | Chief Commercial Officer | 0 | 1954 |
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.
